Increased risk of cardiovascular events with parecoxib/valdecoxib : a systematic review and meta-analysis

Increased risk of cardiovascular events with parecoxib/valdecoxib : a systematic review and meta-analysis

Determines the risk of serious cardiovascular events associated with the use of the COX-2 inhibitor valdecoxib and its prodrug parecoxib following major surgery. Performs a systematic review and meta-analysis of placebo-controlled randomised double-blind clinical trials of IV parecoxib followed by o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:New Zealand medical journal 2005-11, Vol.118 (1226), p.10p
1. Verfasser: Aldington, Sarah
Format: Artikel
Sprache:eng
Schlagworte:
Cardiovascular disease
Clinical trials
Diseases
Drug therapy
Drugs
Heart
Heart attacks
Medicine
Studies
Surgery
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 1226
container_start_page 10p
container_title New Zealand medical journal
container_volume 118
creator Aldington, Sarah
description Determines the risk of serious cardiovascular events associated with the use of the COX-2 inhibitor valdecoxib and its prodrug parecoxib following major surgery. Performs a systematic review and meta-analysis of placebo-controlled randomised double-blind clinical trials of IV parecoxib followed by oral valdecoxib treatment, that presented data on serious cardiovascular events. Calculates the pooled fixed-effects estimates for the odds ratio for risk of cardiovascular events for the use of parecoxib/valdecoxib. Source: National Library of New Zealand Te Puna Matauranga o Aotearoa, licensed by the Department of Internal Affairs for re-use under the Creative Commons Attribution 3.0 New Zealand Licence.
format Article
fullrecord <record><control><sourceid>proquest_nlnz_</sourceid><recordid>TN_cdi_proquest_miscellaneous_17190769</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17190769</sourcerecordid><originalsourceid>FETCH-LOGICAL-n157t-f09b222b7cf1d307c3289841435b2fbe3eebd8801c9eaede339715bab14ce9373</originalsourceid><addsrcrecordid>eNpdkE1LAzEQhoMoWD_-Q0DwtphsdjeJNyl-FApe9FwmySymptma7G5bf70LFQRPzww8vDO8J2TGuawLJXlzSmaMlapQVdWck4uc19Na15rNiF9EmxAyOpp8_qRdSy0k57sRsh0CJIojxj7Tne8_6BYS2m7vzd0IwR1Hek-B5kPucQO9tzTh6HFHITq6wR4KiBAO2ecrctZCyHj9y0vy_vT4Nn8plq_Pi_nDsoi8ln3RMm3KsjTSttwJJq0olVYVr0RtytagQDROKcatRkCHQmjJawOGVxa1kOKS3B5zt6n7GjD3q43PFkOAiN2QV1xyzWSjJ_Hmn7juhjR9OzlMCKkrpvifFUP8XvnocD9R60o2tZaimXqdjv4Aw8xuUg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1033794081</pqid></control><display><type>article</type><title>Increased risk of cardiovascular events with parecoxib/valdecoxib : a systematic review and meta-analysis</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Aldington, Sarah</creator><creatorcontrib>Aldington, Sarah</creatorcontrib><description>Determines the risk of serious cardiovascular events associated with the use of the COX-2 inhibitor valdecoxib and its prodrug parecoxib following major surgery. Performs a systematic review and meta-analysis of placebo-controlled randomised double-blind clinical trials of IV parecoxib followed by oral valdecoxib treatment, that presented data on serious cardiovascular events. Calculates the pooled fixed-effects estimates for the odds ratio for risk of cardiovascular events for the use of parecoxib/valdecoxib. Source: National Library of New Zealand Te Puna Matauranga o Aotearoa, licensed by the Department of Internal Affairs for re-use under the Creative Commons Attribution 3.0 New Zealand Licence.</description><identifier>ISSN: 0028-8446</identifier><identifier>ISSN: 1175-8716</identifier><identifier>EISSN: 1175-8716</identifier><language>eng</language><publisher>Auckland: Pasifika Medical Association Group (PMAG)</publisher><subject>Cardiovascular disease ; Clinical trials ; Diseases ; Drug therapy ; Drugs ; Heart ; Heart attacks ; Medicine ; Studies ; Surgery</subject><ispartof>New Zealand medical journal, 2005-11, Vol.118 (1226), p.10p</ispartof><rights>Copyright New Zealand Medical Association (NZMA) Nov 25, 2005</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttps://natlib-primo.hosted.exlibrisgroup.com/primo-explore/search?query=any,contains,994765973602837&amp;tab=innz&amp;search_scope=INNZ&amp;vid=NLNZ&amp;offset=0$$DView this record in NLNZ$$Hfree_for_read</backlink></links><search><creatorcontrib>Aldington, Sarah</creatorcontrib><title>Increased risk of cardiovascular events with parecoxib/valdecoxib : a systematic review and meta-analysis</title><title>New Zealand medical journal</title><description>Determines the risk of serious cardiovascular events associated with the use of the COX-2 inhibitor valdecoxib and its prodrug parecoxib following major surgery. Performs a systematic review and meta-analysis of placebo-controlled randomised double-blind clinical trials of IV parecoxib followed by oral valdecoxib treatment, that presented data on serious cardiovascular events. Calculates the pooled fixed-effects estimates for the odds ratio for risk of cardiovascular events for the use of parecoxib/valdecoxib. Source: National Library of New Zealand Te Puna Matauranga o Aotearoa, licensed by the Department of Internal Affairs for re-use under the Creative Commons Attribution 3.0 New Zealand Licence.</description><subject>Cardiovascular disease</subject><subject>Clinical trials</subject><subject>Diseases</subject><subject>Drug therapy</subject><subject>Drugs</subject><subject>Heart</subject><subject>Heart attacks</subject><subject>Medicine</subject><subject>Studies</subject><subject>Surgery</subject><issn>0028-8446</issn><issn>1175-8716</issn><issn>1175-8716</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNpdkE1LAzEQhoMoWD_-Q0DwtphsdjeJNyl-FApe9FwmySymptma7G5bf70LFQRPzww8vDO8J2TGuawLJXlzSmaMlapQVdWck4uc19Na15rNiF9EmxAyOpp8_qRdSy0k57sRsh0CJIojxj7Tne8_6BYS2m7vzd0IwR1Hek-B5kPucQO9tzTh6HFHITq6wR4KiBAO2ecrctZCyHj9y0vy_vT4Nn8plq_Pi_nDsoi8ln3RMm3KsjTSttwJJq0olVYVr0RtytagQDROKcatRkCHQmjJawOGVxa1kOKS3B5zt6n7GjD3q43PFkOAiN2QV1xyzWSjJ_Hmn7juhjR9OzlMCKkrpvifFUP8XvnocD9R60o2tZaimXqdjv4Aw8xuUg</recordid><startdate>20051125</startdate><enddate>20051125</enddate><creator>Aldington, Sarah</creator><general>Pasifika Medical Association Group (PMAG)</general><scope>DUNLO</scope><scope>GOM</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AYAGU</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7T2</scope><scope>7U1</scope><scope>7U2</scope><scope>C1K</scope></search><sort><creationdate>20051125</creationdate><title>Increased risk of cardiovascular events with parecoxib/valdecoxib : a systematic review and meta-analysis</title><author>Aldington, Sarah</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-n157t-f09b222b7cf1d307c3289841435b2fbe3eebd8801c9eaede339715bab14ce9373</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Cardiovascular disease</topic><topic>Clinical trials</topic><topic>Diseases</topic><topic>Drug therapy</topic><topic>Drugs</topic><topic>Heart</topic><topic>Heart attacks</topic><topic>Medicine</topic><topic>Studies</topic><topic>Surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aldington, Sarah</creatorcontrib><collection>Index New Zealand (A&amp;I)</collection><collection>Index New Zealand</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Australia &amp; New Zealand Database</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Risk Abstracts</collection><collection>Safety Science and Risk</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>New Zealand medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aldington, Sarah</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Increased risk of cardiovascular events with parecoxib/valdecoxib : a systematic review and meta-analysis</atitle><jtitle>New Zealand medical journal</jtitle><date>2005-11-25</date><risdate>2005</risdate><volume>118</volume><issue>1226</issue><spage>10p</spage><pages>10p-</pages><issn>0028-8446</issn><issn>1175-8716</issn><eissn>1175-8716</eissn><abstract>Determines the risk of serious cardiovascular events associated with the use of the COX-2 inhibitor valdecoxib and its prodrug parecoxib following major surgery. Performs a systematic review and meta-analysis of placebo-controlled randomised double-blind clinical trials of IV parecoxib followed by oral valdecoxib treatment, that presented data on serious cardiovascular events. Calculates the pooled fixed-effects estimates for the odds ratio for risk of cardiovascular events for the use of parecoxib/valdecoxib. Source: National Library of New Zealand Te Puna Matauranga o Aotearoa, licensed by the Department of Internal Affairs for re-use under the Creative Commons Attribution 3.0 New Zealand Licence.</abstract><cop>Auckland</cop><pub>Pasifika Medical Association Group (PMAG)</pub></addata></record>
fulltext fulltext
identifier ISSN: 0028-8446
ispartof New Zealand medical journal, 2005-11, Vol.118 (1226), p.10p
issn 0028-8446
1175-8716
1175-8716
language eng
recordid cdi_proquest_miscellaneous_17190769
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Cardiovascular disease
Clinical trials
Diseases
Drug therapy
Drugs
Heart
Heart attacks
Medicine
Studies
Surgery
title Increased risk of cardiovascular events with parecoxib/valdecoxib : a systematic review and meta-analysis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T02%3A11%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_nlnz_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Increased%20risk%20of%20cardiovascular%20events%20with%20parecoxib/valdecoxib%20:%20a%20systematic%20review%20and%20meta-analysis&rft.jtitle=New%20Zealand%20medical%20journal&rft.au=Aldington,%20Sarah&rft.date=2005-11-25&rft.volume=118&rft.issue=1226&rft.spage=10p&rft.pages=10p-&rft.issn=0028-8446&rft.eissn=1175-8716&rft_id=info:doi/&rft_dat=%3Cproquest_nlnz_%3E17190769%3C/proquest_nlnz_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1033794081&rft_id=info:pmid/&rfr_iscdi=true